Ledger.Open graph →
SEC Form D · filed August 25, 2021

Vigil Neuroscience, Inc

Offering
$90.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Ivana Magovcevic-Liebisch · Cambridge, MAExec · DirectorStefan Vitorovic · Boston, MADirectorShaan Gandhi · Durham, NCDirectorBruce Booth · Waltham, MADirectorGerhard Koenig · Cambridge, MADirectorCheryl Blanchard, Ph. D · Cambridge, MADirectorJennifer Ziolkowski · Cambridge, MAExecClay Thorp · Nashville, TNDirectorStefan Vitorovic · Boston, MADirectorShaan Gandhi · Durham, NCDirectorBruce Booth · Cambridge, MADirectorGerhard Koenig · Cambridge, MADirectorCheryl Blanchard, Ph. D · Cambridge, MADirectorJennifer Ziolkowski · Cambridge, MAExecClay Thorp · Malvern, PADirectorIvana Magovcevic-Liebisch · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗